RAMM Pharma, a cannabis-based pharmaceutical company with products in several Latin American countries, has bought Sicilian CBD processing company Canapar in an all-stock transaction worth about $22 million ($26.2 million Canadian dollars). Based in Toronto, RAMM purchased 49% of Canapar stock earlier this year. The transaction announced Wednesday has RAMM paying 21.9 million shares worth […]